!!Projects per year
指紋
查看啟用 臺北醫學大學臺北心臟醫學研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
概要
專案
- 152 已完成
-
-
探討UBE2S在 Oxaliplatin抗藥性大腸癌中的DNA修補功能與評估小分子物SMDB1在臨床上的治療
Cheng, C.-H. (PI)
1/1/21 → 12/31/21
研究計畫: B - 校內計畫 › h - 教育部-深耕計畫
-
Engineering and Optimization of Nano-enabled Targeting and Therapeutic System
Mi, F.-L. (PI)
1/1/21 → 12/31/21
研究計畫: B - 校內計畫 › h - 教育部-深耕計畫
-
2026 Taiwan society of lipids and atherosclerosis consensus statement for the identification and management of patients receiving suboptimally tolerable statins
Wu, Y. J., Yeh, C. F., Hsu, C. Y., Lin, C. F., Huang, C. C., Tang, S. C., Huang, Y. C., Lin, C. Y., Yu, C. H., Huang, C. Y., Wang, C. Y., Huang, P. H., Yeh, H. I., Li, Y. H. & Liu, P. Y., 2026, 於: Journal of the Formosan Medical Association.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
2-Hydroxyl hispolon reverses high glucose-induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO-1 pathways
Wang, T. J., Hou, W. C., Hsiao, B. Y., Lo, T. H., Chen, Y. T., Yang, C. H., Shih, Y. T. & Liu, J. C., 2026, 於: British Journal of Pharmacology. 183, 1, p. 189-211 23 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 連結會在新分頁中打開 引文 斯高帕斯（Scopus） -
Advanced glycation end products enhance human atrial fibroblast activity through activation of interferon/signal transducer and activator of transcription signaling
Cheng, T. Y., Li, S. J., Lee, T. W., Lee, T. I., Chen, Y. C., Kao, Y. H., Higa, S., Chen, P. H. & Chen, Y. J., 3月 2026, 於: Gene Reports. 42, 102423.研究成果: 雜誌貢獻 › 文章 › 同行評審
資料集
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
資料集: Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
資料集: Dataset
-
Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Chien, C.-L. (Contributor), Chen, Y.-C. (Contributor), Malone, D. C. (Creator), Peng, Y.-L. (Contributor) & Ko, Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.12871744.v1, https://tandf.figshare.com/articles/dataset/Cost-utility_analysis_of_second-line_anti-diabetic_therapy_in_patients_with_type_2_diabetes_mellitus_inadequately_controlled_on_metformin/12871744/1
資料集: Dataset